Pakistan’s pharmaceutical exports have seen impressive growth, with a 31.11% increase in the first quarter of the 2024-25 financial year compared to the same period in 2023. According to the Pakistan Bureau of Statistics (PBS), pharmaceutical exports reached a total of $105.936 million from July to September 2024. This marks a significant rise from $80.796 million during the same months in 2023.
In September 2024 alone, the sector experienced an outstanding 61.55% year-on-year increase, with exports reaching $43.607 million, up from $26.992 million in September 2023. This was also a 53.78% rise compared to August 2024, when exports were $28.357 million.
This remarkable growth highlights the expanding strength and global competitiveness of Pakistan’s pharmaceutical industry. The increase in exports not only reflects the industry’s capabilities but also shows the growing demand for pharmaceutical products made in Pakistan. As the industry continues to grow, it reinforces Pakistan’s position in the global healthcare market and demonstrates innovation and progress in the sector.
The surge in pharmaceutical exports is a promising sign for the future, demonstrating how the country’s healthcare industry is advancing and becoming more recognized on the international stage. This success is expected to contribute significantly to Pakistan’s economy, making the pharmaceutical sector a key player in the country’s export growth.
